Skip to content

MyChart Proxy Outreach to Parents (MyPOP)

MyChart Proxy Outreach to Parents (MyPOP): Mode of Outreach to Parents for Proxy Patient Portal Enrollment

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT05989308
Acronym
MyPOP
Enrollment
5200
Registered
2023-08-14
Start date
2024-10-15
Completion date
2026-09-01
Last updated
2026-02-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Technology

Brief summary

The goal of this randomized controlled trial is to assess the extent to which different modes of contacting parents who have not yet enabled to access to their children's medical records will result in greater proxy access. The main questions the study aims to answer are: * will outreach via text or patient portal message result in more parents having access than usual care (which is in-office suggestions to get access). * which mode - text or portal - will get more parents access. Participants will get a text message, or a portal message through their own patient portal, or no message. The investigators will check access to see which group has increased more during the study period.

Detailed description

This study aims to evaluate the feasibility and impact of contacting parents/guardians of children seen in pediatric primary care practices to establish their proxy access to the EHR patient portal, called "MyChart." The primary objective of the study is to determine if directly messaging a guardian results in activation of proxy access to a child's MyChart at a higher rate compared with no specific messaging (usual care). A secondary objective of the study is to compare messaging strategies, with one arm being a message to the guardian's patient portal, and the other text messaging. Another secondary objective of the study is to ascertain whether sending information about activation to a guardian via text or email (as preferred) will result in self-activating their own Electronic Health Record (EHR) patient portal access. At the conclusion of the study, the investigators will determine best-method for activation and utilize this method to invite guardians initially randomized to the usual-care arm of the study.

Interventions

BEHAVIORALEmail

Email message sent to guardian with proxy information.

BEHAVIORALText

Text message sent to guardian with proxy information.

Patient portal message (MyChart) to guardian with proxy information.

Sponsors

Yale University
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
HEALTH_SERVICES_RESEARCH
Masking
NONE

Intervention model description

JDAT will access EHR visit data for these offices to establish the child patient pool and identify guardians.

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
Yes

Inclusion criteria

* Guardian of a child aged ≤12 years seen in one of the two identified health centers within the last 3 years with guardian status and contact information documented in the child's EHR

Exclusion criteria

* Preferred method of contact for guardians with no MyChart is telephone or physical letter to home * Guardians with EHR proxy access already activated for all children in their care.

Design outcomes

Primary

MeasureTime frameDescription
Proportion of participants who activate MyChart Proxy Accessup to 12 weeksProportion of participants who activate access to the patient portal of the child's EHR, also known as MyChart Proxy Access, of all those invited. Proxy MyChart activation is a binary function (yes, has proxy activated; no, does not have proxy activated).

Secondary

MeasureTime frameDescription
Proportion of guardians' who activate a personal MyChart accountup to 12 weeksProportion of guardians' who activate a personal MyChart account, for those without accounts at the outset. Investigators will report if guardians activate their patient portal as a result of activation messaging. This is a binary function (yes, has active patient portal; no, does not have active patient portal).

Countries

United States

Contacts

CONTACTAda Fenick, MD
Ada.fenick@yale.edu203-688-2475
PRINCIPAL_INVESTIGATORAda Fenick, MD

Yale University

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 14, 2026